Timothy Kelly
Vermögen: 112 613 $ am 31.08.2026
Vermögen: 112 613 $ am 31.08.2026
Mr. Timothy P.
Kelly is a Chief Technical Officer at Abivax SA. Mr. Kelly was previously employed as a Chief Technology Officer by Caribou Biosciences, Inc., a Chairman & Chief Executive Officer by Oxford Biomedica Solutions LLC, a Chief Operating Officer by Homology Medicines, Inc., a Head-Technical Operations by Sarepta Therapeutics, Inc., a Head-Technical Operations by Shire Plc, a Head-Technical Operations by UCB SA, and a Senior Director-International Operations by Biogen Idec, Inc. He received his undergraduate degree from United States Air Force Academy and an MBA from Troy University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.02.2026 | 73 125 ( 0,07 % ) | 112 613 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ABIVAX | Technik-/Wissenschafts-/F&E-Leiter | 21.09.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
Oxford Biomedica Solutions LLC
Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Operates as an AAV focused manufacturing and innovation company | Vorstandsvorsitzender | 01.07.2023 |
| Q32 BIO INC. | Geschäftsführer | 10.03.2022 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.05.2017 |
| SHIRE | Corporate Officer/Principal | 01.01.2017 |
| UCB | Corporate Officer/Principal | 01.01.2009 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Caribou Biosciences, Inc.
Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
UCB SA
UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
United States Air Force Academy
United States Air Force Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Troy University
Troy University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Homology Medicines, Inc.
Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Oxford Biomedica Solutions LLC
Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Operates as an AAV focused manufacturing and innovation company | Producer Manufacturing |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen